Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Agnes E. Ubani, MD
WARNING LETTER
•Agnes E. Ubani, MD•June 6, 2013

Agnes E. Ubani, MD – FDA Warning Letter, Jun 6, 2013

Record Details

The FDA issued a Warning Letter to Dr. Agnes Ubani of Windsor Medical Clinic following an inspection conducted from May 29 to June 6, 2013. The inspection, part of the Bioresearch Monitoring Program, reviewed Dr. Ubani's conduct of two clinical investigations: Protocol 1245.25 for Boehringer Ingelheim Pharmaceuticals, Inc. and Protocol H9X-MC-GBDN for Eli Lilly and Company. The FDA concluded that Dr. Ubani failed to adhere to applicable statutory requirements and FDA regulations governing clinical investigations. Two primary violations were identified. First, Dr. Ubani failed to ensure the investigation was conducted according to the investigational plan [21 CFR 312.60], specifically by enrolling subjects who did not meet inclusion/exclusion criteria for Protocol 1245.25, including those with a history of cancer, lacking high cardiovascular risk, or having uncontrolled hyperglycemia. This affected 50% of enrolled subjects in that protocol, jeopardizing subject safety and data validity. The corrective action plan for eligibility screening was deemed inadequate due to lack of detail. Second, Dr. Ubani failed to maintain adequate and accurate case histories [21 CFR 312.62(b)], evidenced by discrepancies in signature dates on laboratory reports, raising concerns about data validity and integrity. The proposed corrective action for case histories was also deemed inadequate. Dr. Ubani must address these deficiencies and establish procedures for future compliance. A written response detailing corrective actions is required within fifteen working days to prevent further regulatory action.

Company
Agnes E. Ubani, MD
Inspection date
June 6, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas N. Moreno
View Company Profile

ID · d61271a8-3a11-4b5c-af93-9f03d6c14b44

Violation Codes2
21 CFR 312.6021 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Agnes E. Ubani, MD
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.